methylprednisolone and Hantavirus Pulmonary Syndrome

methylprednisolone has been researched along with Hantavirus Pulmonary Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belmar, E; Calvo, M; Castillo, C; Cuiza, A; Díaz, R; Ferres, M; Hernandez, C; Lee, SJ; Martinez, J; Mertz, GJ; Rioseco, ML; Riquelme, R; Scholz, L; Valdivieso, F; Vial, PA1

Trials

1 trial(s) available for methylprednisolone and Hantavirus Pulmonary Syndrome

ArticleYear
High-dose intravenous methylprednisolone for hantavirus cardiopulmonary syndrome in Chile: a double-blind, randomized controlled clinical trial.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:7

    Topics: Administration, Intravenous; Adolescent; Adult; Anti-Inflammatory Agents; Chile; Double-Blind Method; Female; Hantavirus Pulmonary Syndrome; Humans; Kaplan-Meier Estimate; Male; Methylprednisolone; Middle Aged; Orthohantavirus; RNA, Viral; Treatment Outcome

2013